Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 54


Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.

Nam HW, Karpyak VM, Hinton DJ, Geske JR, Ho AM, Prieto ML, Biernacka JM, Frye MA, Weinshilboum RM, Choi DS.

Transl Psychiatry. 2015 Aug 18;5:e621. doi: 10.1038/tp.2015.120.


Molecular basis of alcoholism.

Most D, Ferguson L, Harris RA.

Handb Clin Neurol. 2014;125:89-111. doi: 10.1016/B978-0-444-62619-6.00006-9.


Alcoholic liver disease: treatment.

Suk KT, Kim MY, Baik SK.

World J Gastroenterol. 2014 Sep 28;20(36):12934-44. doi: 10.3748/wjg.v20.i36.12934. Review.


The development of acamprosate as a treatment against alcohol relapse.

Kufahl PR, Watterson LR, Olive MF.

Expert Opin Drug Discov. 2014 Nov;9(11):1355-69. doi: 10.1517/17460441.2014.960840. Epub 2014 Sep 26. Review.


Hypothalamic peptides controlling alcohol intake: differential effects on microstructure of drinking bouts.

Chen YW, Barson JR, Chen A, Hoebel BG, Leibowitz SF.

Alcohol. 2014 Nov;48(7):657-64. doi: 10.1016/j.alcohol.2014.08.005. Epub 2014 Aug 20.


A Bayesian mixed-treatment comparison meta-analysis of treatments for alcohol dependence and implications for planning future trials.

DeSantis SM, Zhu H.

Med Decis Making. 2014 Oct;34(7):899-910. doi: 10.1177/0272989X14537558. Epub 2014 Jun 16. Review.


PTSD and comorbid AUD: a review of pharmacological and alternative treatment options.

Ralevski E, Olivera-Figueroa LA, Petrakis I.

Subst Abuse Rehabil. 2014 Mar 7;5:25-36. doi: 10.2147/SAR.S37399. eCollection 2014. Review.


Therapy for alcoholic liver disease.

Jaurigue MM, Cappell MS.

World J Gastroenterol. 2014 Mar 7;20(9):2143-58. doi: 10.3748/wjg.v20.i9.2143. Review.


MT-7716, a novel selective nonpeptidergic NOP receptor agonist, effectively blocks ethanol-induced increase in GABAergic transmission in the rat central amygdala.

Kallupi M, Oleata CS, Luu G, Teshima K, Ciccocioppo R, Roberto M.

Front Integr Neurosci. 2014 Feb 18;8:18. doi: 10.3389/fnint.2014.00018. eCollection 2014.


Pharmacological approaches to reducing craving in patients with alcohol use disorders.

Haass-Koffler CL, Leggio L, Kenna GA.

CNS Drugs. 2014 Apr;28(4):343-60. doi: 10.1007/s40263-014-0149-3. Review.


Event-Related Oscillations in Alcoholism Research: A Review.

Pandey AK, Kamarajan C, Rangaswamy M, Porjesz B.

J Addict Res Ther. 2012 Jan 12;Suppl 7(1). pii: 3844.


KASL clinical practice guidelines: management of alcoholic liver disease.

Korean Association for the Study of the Liver (KASL).

Clin Mol Hepatol. 2013 Sep;19(3):216-54. doi: 10.3350/cmh.2013.19.3.216. Epub 2013 Sep 30. No abstract available.


The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies.

Litten RZ, Castle IJ, Falk D, Ryan M, Fertig J, Chen CM, Yi HY.

Alcohol Clin Exp Res. 2013 Dec;37(12):2128-37. doi: 10.1111/acer.12197. Epub 2013 Jul 24.


Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review.

Brennan JL, Leung JG, Gagliardi JP, Rivelli SK, Muzyk AJ.

Clin Pharmacol. 2013 Jul 3;5:99-107. doi: 10.2147/CPAA.S32434. Print 2013.


Pharmacotherapies for Overeating and Obesity.

Yarnell S, Oscar-Berman M, Avena N, Blum K, Gold M.

J Genet Syndr Gene Ther. 2013 Apr 1;4(3):131.


Treatment of co-occurring alcohol and other drug use disorders.

Arias AJ, Kranzler HR.

Alcohol Res Health. 2008;31(2):155-67. Review.


Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism.

Krishnan-Sarin S, O'Malley S, Krystal JH.

Alcohol Res Health. 2008;31(4):400-7. Review.


The past and future of research on treatment of alcohol dependence.

Willenbring ML.

Alcohol Res Health. 2010;33(1-2):55-63. Review.


Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study.

DeSantis SM, Bandyopadhyay D, Baker NL, Randall PK, Anton RF, Prisciandaro JJ.

Drug Alcohol Depend. 2013 Sep 1;132(1-2):244-50. doi: 10.1016/j.drugalcdep.2013.02.013. Epub 2013 Apr 6.


Safety and efficacy of acamprosate for the treatment of alcohol dependence.

Yahn SL, Watterson LR, Olive MF.

Subst Abuse. 2013;6:1-12. doi: 10.4137/SART.S9345. Epub 2013 Jan 31.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk